Sellas Life Sciences Group Inc's Company Valuation
Currency: USD Updated: 2026-09-04
Previous score
9.62
Change
0
The current valuation score of Sellas Life Sciences Group Inc is 9.62, ranking 17 out of 368 in the Biotechnology & Medical Research industry. Its current P/E ratio is -60.57, which is -99.38% below the recent high of -0.38 and -11.54% above the recent low of -67.56.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.